Disease: Large B-cell Lymphoma
Indication: Treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.
Company: Kite Pharma
Notable Transactions: Gilead acquired Kite Pharma for $12B
Methods: The patient sits for leukapheresis, and the product is sent to a lab. There, the T cells are genetically enhanced to attack cancerous cells and expanded.
Current Phase: FDA Approved
Subscribe to our newsletter to keep up to date with all the latest news about AGT!